| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |